Skip to main content

Form 8.3 – AXA INVESTMENT MANAGERS: NCC Group plc

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: AXA Investment Managers S.A.(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.  (c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree NCC Group plc(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:  (e)   Date position held/dealing undertaken:        For an opening...

Continue reading

BingEx Limited Announces Second Quarter 2025 Financial Results

BEIJING, Aug. 19, 2025 (GLOBE NEWSWIRE) — BingEx Limited (the “Company”) (Nasdaq: FLX), a leading on-demand dedicated courier service provider in China (branded as “FlashEx”), today announced its unaudited financial results for the second quarter ended June 30, 2025. Second Quarter 2025 Highlights:Revenues were RMB1,024.6 million (US$143.0 million) in the second quarter of 2025, compared with RMB1,176.7 million in the same period of 2024. Gross profit was RMB122.7 million (US$17.1 million) in the second quarter of 2025, compared with RMB127.0 million in the same period of 2024. Gross profit margin reached 12.0%, improving from 10.8% in the same period of 2024. Income from operations was RMB19.3 million (US$2.7 million) in the second quarter of 2025, compared with RMB42.3 million in the same period of 2024. Non-GAAP income from...

Continue reading

XPENG Reports Second Quarter 2025 Unaudited Financial Results

Cash and cash equivalents, restricted cash, short-term investments and time deposits were RMB47.57 billion (US$6.64 billion) as of June 30, 2025 Quarterly total revenues were RMB18.27 billion, a 125.3% increase year-over-year Quarterly gross margin was 17.3%, an increase of 3.3 percentage points over the same period of 2024 Quarterly vehicle margin was 14.3%, an increase of 7.9 percentage points over the same period of 2024GUANGZHOU, China, Aug. 19, 2025 (GLOBE NEWSWIRE) — XPeng Inc. (“XPENG” or the “Company,” NYSE: XPEV and HKEX: 9868), a leading Chinese smart electric vehicle (“Smart EV”) company, today announced its unaudited financial results for the three months ended June 30, 2025. Operational and Financial Highlights for the Three Months Ended June 30, 2025  2025Q2 2025Q1 2024Q4 2024Q3 2024Q2 2024Q1             Total...

Continue reading

Novaturas presented financial results for the first half of 2025

On April 19, 2025, at 9:00 AM, the CEO of AB “Novaturas,” Mr. Kristijonas Kaikaris, and the Interim Chief Financial Officer, Ms. Auksė Kriaučiūnaitė, presented the company’s consolidated financial results for the first half of 2025 to investors. Link to webinar record: https://youtu.be/imNGJgVPvHw. Performance of Novaturas Group for the 1st half-year of 2025 (EUR 000’s):  Financial indicators H1 2025 H1 2024 H1 2023Revenue 74,142 91,320   101,351Gross profit 8,926 8,507   15,426EBITDA (254) (1,565)  5,667Net profit (loss) (791) (2,277)  4,582About the company The Novaturas Group is a tour operator offering the widest range of travel destinations from the Baltic States. It has been operating in the region for more than 25 years. The company offers summer and winter recreational, sightseeing, exotic, skiing, workation...

Continue reading

CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers

SHENZHEN, CHINA, Aug. 19, 2025 (GLOBE NEWSWIRE) — On 18 August, China Medical System Holdings Limited (“CMS” or the “Company”) announced its interim results for the six months ended 30 June 2025 (the “Reporting Period”), with both revenue and profit recording year-on-year growth, demonstrating the initial results of its strategic transformation. During the Reporting Period, the Company recorded revenue of approximately RMB4.00 billion, representing a year-on-year increase of 10.8%. In the case that all medicines were directly sold by the Company, revenue would be approximately RMB4.67 billion, up 8.9% year-on-year. Net profit was approximately RMB0.93 billion, representing an increase of 3.1% year-on-year. The results reflect that CMS has emerged from the shadow of National Volume-based Procurement (“National VBP”), and its performance...

Continue reading

Cloudera Acquires Taikun to Deliver Cloud Experience to Data Anywhere for AI Everywhere

Acquisition accelerates Cloudera’s mission to enable enterprises to take back control of their data estates across any environment SANTA CLARA, Calif., Aug. 19, 2025 (GLOBE NEWSWIRE) — Cloudera, the only data and AI platform company that brings the cloud anywhere, today announced its acquisition of Taikun, a leading platform provider for managing Kubernetes and cloud infrastructure across hybrid and multi-cloud environments. With this move, Cloudera accelerates the deployment and delivery of the complete Cloudera platform, including Data Services and AI anywhere – from the public clouds to on-prem data centers to sovereign and air-gapped environments – all through a unified control plane. As enterprise IT environments become more complex and distributed, the need for reliable and scalable data infrastructure has become increasingly...

Continue reading

MT Højgaard Holding A/S: Consolidation and strengthening of order portfolio in Q2

SECOND-QUARTER RESULTS (Comparative figures for the second quarter of 2024 are shown in brackets) The second quarter was characterised by high production and a significant intake of new orders. Revenue and operating profit developed in line with the full-year expectations, and profit after tax improved following the winding-up of loss-making international activities.Revenue amounted to DKK 2,675 million (DKK 2,665 million), Enemærke & Petersen recorded growth, while MT Højgaard Danmark experienced a slight decline in activity due to quarter-on-quarter fluctuations. The gross margin improved, driven by MT Højgaard Danmark, while a number of projects continued to weigh on Enemærke & Petersen’s margin. The operating profit (EBIT) of DKK 100 million (DKK 124 million) was affected by investments in capacity building and losses...

Continue reading

Interim Financial Report, H1 2025

Jyske Realkredit A/S – Interim Financial Report, H1 2025 To NASDAQ Copenhagen A/S                                                                                                                  19 August 2025                                                                                                                 Announcement No. 67/2025 Interim Financial Report, H1 2025 On August 19, 2025, the Supervisory Board has approved the Interim Financial Report, H1 2025 of Jyske Realkredit A/S. Please see the attached file. Yours sincerely,Jyske Realkredit A/S Anders Lund HansenCEO Direct phone (+45) 89 89 92 20E-mail: alh@jyskerealkredit.dk Web: jyskerealkredit.dk Please observe that the Danish version of this announcement prevails. Attached files:Interim Financial Report of Jyske Realkredit H1 2025.pdfAttachment...

Continue reading

Interim Financial Report, H1 2025

Expected net profit in 2025 specified at the upper end of DKK 3.8bn-4.6bn, equivalent to earnings per share at the upper end of DKK 60-73 Earnings per share at DKK 39.4 (H1 2024: DKK 38.8) Core income at DKK 6,503m (H1 2024: DKK 6,828m) Core expenses at DKK 3,195m (H1 2024: DKK 3,160m) Loan impairment charges: income of DKK 47m (H1 2024: expense of DKK 95m) Management’s estimate relating to loan impairment charges at DKK 1,877m (end of 2024: DKK 1,782m) Capital ratio at 21.5%, of which common equity tier 1 capital ratio at 16.3% (H1 2024: 21.9% and 16.6%, respectively)Summary ”Overall, we are seeing good activity and have refined our outlook. Over the past year, Jyske Bank significantly improved customer satisfaction among both personal and corporate customers and was named “Best at Private Banking” for the tenth year running....

Continue reading

Coloplast A/S – Interim Financial Report, 9M 2024/25

2024/25 Interim financial results, 9M 2024/25 1 October 2024 – 30 June 2025 Coloplast delivered organic growth of 7% and an EBIT margin1 of 28% in Q3. Reported revenue in DKK grew 1% with negative impact from currencies and the Skin Care divestment.Organic growth rates by business area: Ostomy Care 6%, Continence Care 8%, Voice and Respiratory Care 9%, Advanced Wound Care 4% and Interventional Urology 4%. Growth in Ostomy Care was driven by broad-based contribution across regions, except for China which delivered low-single digit growth, as expected. Growth in Continence Care was driven by continued strong contribution from the Luja™ portfolio. Voice and Respiratory Care growth was driven by continued good momentum in both Laryngectomy and Tracheostomy. Growth in Advanced Wound Dressings was -2%, driven primarily by a significant...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.